lorcaserin(856681-05-5)is an orally administered agent and a selective 5-ht2c receptor agonist for the treatment of obesity. it had been approved for marketing in us by fda on 27 june in 2012. in clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
ethyl trifluoroacetate basic information |
product name: | ethyl trifluoroacetate |
synonyms: | aceticacid,trifluoro-,ethylester;cf3cooc2h5;ethyl ester of trifluoroacetic acid;ethyl trifluoroethanoate;ethylperfluoroacetate;trifluoressigsαureethylester;trifluoro-aceticaciethylester;ethyl 2,2,2-trifluoroacetate |
cas: | 383-63-1 |
mf: | c4h5f3o2 |
mw: | 142.08 |
einecs: | 206-851-6 |
product categories: | fluoro-aliphatics ;acetics acid and esters;organic fluorides;fluorinated building blocks;fluorinating reagents & building blocks for fluorinated biochemical compounds;synthetic organic chemistry;organofluorine compounds;building blocks;c2 to c5;carbonyl compounds;chemical synthesis;esters;organic building blocks;pharmaceutical intermediates |
mol file: | 383-63-1.mol |
ethyl trifluoroacetate chemical properties |
mp | -78 °c |
bp | 60-62 °c(lit.) |
density | 1.194 g/ml at 25 °c(lit.) |
refractive index |
n |
fp | 30 °f |
storage temp. | 2-8°c |
water solubility | hydrolysis |
sensitive | moisture sensitive |
brn | 1761411 |
cas database reference | 383-63-1(cas database reference) |
nist chemistry reference | acetic acid, trifluoro-, ethyl ester(383-63-1) |